By Raji Unnikrishnan
A COCKTAIL of antibodies designed to resist coronavirus (Covid-19) is the latest addition to Bahrain’s upfront measures in fighting the spread of infection.
Regn-Cov2, an artificial drug for prophylaxis – which is the treatment given or action taken to prevent disease – is being administered to citizens and residents at the A’ali Al Shamil Centre since yesterday.
Studies have shown that the drug, approved by the US Food and Drug Administration (FDA), helps in preventing infection among those who have come in contact with Covid-19 positive cases by 81 per cent, as well as limiting the symptoms in those infected.
Click here to read more.
